Pate D W, Järvinen K, Urtti A, Jarho P, Mahadevan V, Järvinen T
Department of Pharmaceutical Chemistry, University of Kuopio, Finland.
Pharm Res. 1997 Dec;14(12):1738-43. doi: 10.1023/a:1012131929940.
Anandamides have been observed to lower intraocular pressure in the rabbit eye, preceded by a period of hypertension. Amidases are thought to catabolize these compounds into their component parts, including arachidonic acid. Direct application of arachidonic acid has been observed to cause a marked rise of intraocular pressure. Thus, anandamide analogs resistant to catabolism were thought possibly devoid of this initial hypertension, and their effects on rabbit IOP investigated.
A series of chiral alpha-substituted anandamides were synthesized and studied for their effect on the intraocular pressure (IOP) of normotensive pigmented rabbits. Each test compound was dissolved in an aqueous 2-hydroxypropyl-beta-cyclodextrin solution (containing 3% polyvinyl alcohol) and administered (62.5 micrograms) unilaterally to the eye.
The most promising compounds caused a statistically significant reduction of IOP (vs. vehicle) in the treated eyes. Of these, the R-alpha-isopropyl compound exhibited the best activity tested. Unlike the alpha-unsubstituted analogs previously studied, hypotensive effects were not preceded by an initial elevation of IOP and indomethacin pre-treatment (12.5 mg, s.c.) did not eliminate the IOP response, as demonstrated by administered R-alpha-isopropyl anandamide.
Catabolism of alpha-unsubstituted anandamides may account for their observed intraocular hypertensive effects. The physiological mechanism by which alpha-substituted anandamides work apparently differs from that of the more easily metabolized alpha-unsubstituted compounds.
已观察到花生四烯酸乙醇胺在兔眼中可降低眼压,在此之前会有一段高血压期。酰胺酶被认为可将这些化合物分解为其组成部分,包括花生四烯酸。已观察到直接应用花生四烯酸会导致眼压显著升高。因此,认为对分解代谢有抗性的花生四烯酸乙醇胺类似物可能不会出现这种初始高血压,并对其对兔眼压的影响进行了研究。
合成了一系列手性α-取代的花生四烯酸乙醇胺,并研究了它们对正常血压的有色兔眼压(IOP)的影响。每种测试化合物都溶解在含2-羟丙基-β-环糊精的水溶液(含有3%聚乙烯醇)中,并以单侧给药(62.5微克)的方式注入眼中。
最有前景的化合物使治疗眼的眼压(与赋形剂相比)出现了具有统计学意义的降低。其中,R-α-异丙基化合物表现出了所测试的最佳活性。与先前研究的α-未取代类似物不同,降压作用之前没有眼压的初始升高,并且如给予R-α-异丙基花生四烯酸乙醇胺所证明的,吲哚美辛预处理(12.5毫克,皮下注射)并未消除眼压反应。
α-未取代的花生四烯酸乙醇胺的分解代谢可能是其观察到的眼内高血压作用的原因。α-取代的花生四烯酸乙醇胺起作用的生理机制显然与更易代谢的α-未取代化合物不同。